Evidence map›Paper›PMID 27869820›Full record

ArticleNature immunology2017

TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells.

Ageliki Tsagaratou, Edahí González-Avalos, Sini Rautio, James P Scott-Browne, Susan Togher, William A Pastor, Ellen V Rothenberg, Lukas Chavez, Harri Lähdesmäki, Anjana Rao

Abstract read
In one paragraph

Article in Nature immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Targeting RUNX1 Germline Variants: Agents Under Investigation.Current hematologic malignancy reports · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Innateness transcriptome gradients characterize mouse T lymphocyte populations.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Ageliki TsagaratouDepartment of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Edahí González-AvalosDepartment of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Sini RautioDepartment of Computer Science, Aalto University School of Science, Aalto, Finland.
James P Scott-BrowneDepartment of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Susan TogherDepartment of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
William A PastorDepartment of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
Ellen V RothenbergDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.ORCID 0000-0002-3901-347X
Lukas ChavezDivision of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Harri LähdesmäkiDepartment of Computer Science, Aalto University School of Science, Aalto, Finland.
Anjana RaoDepartment of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.
La Jolla Institute for Immunology · USAalto University · FICalifornia Institute of Technology · USGerman Cancer Research Center · DE

Funding

The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancerR35CA210043 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Anjana Rao · 2016 to 2026
$10.6M
REGULATED ACCESSIBILITY OF A CYTOKINE GENE LOCUSR01AI044432 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 1999 to 2014
$7.7M
Role of TET proteins in myeloid malignanciesR01CA151535 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2012 to 2016
$1.8M
Illumina HiSeq 2500 Sequencing SystemS10OD016262 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2013 to 2013
$600k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NCI NIH HHS R01 CA151535NCI NIH HHS R35 CA210043NIAID NIH HHS R01 AI044432NIH HHS S10 OD016262
6 · The paper itself

Abstract

TET proteins oxidize 5-methylcytosine in DNA to 5-hydroxymethylcytosine and other oxidation products. We found that simultaneous deletion of Tet2 and Tet3 in mouse CD4

Indexed as

Cell DifferentiationAnimalsAntigens, CD1dCD4 AntigensCD8 AntigensCell LineageCell ProliferationCells, CulturedDioxygenasesDNA-Binding ProteinsDNA MethylationMiceMice, Inbred C57BLMice, KnockoutNatural Killer T-CellsPrecursor Cells, T-LymphoidAntigens, CD1dCD1d antigen, mouseCD4 AntigensCD8 AntigensDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsReceptors, Antigen, T-CellT-bet Transcription FactorT-Box Domain ProteinsTet2 protein, mouseTet3 protein, mouseTranscription FactorsZbtb7b protein, mouse

Identifiers

PMID27869820
PMCPMC5376256
OpenAlexW2552807099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.